Form 4 Edwards Lifesciences For: May 03 Filed by: Chopra Daveen
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.MarketBeat
- Global Cardiac Surgery Market Analysis 2024: Innovative Cardiac Procedures Drive Market Expansion with 5.5% CAGR through 2030 [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences hit with Meril's EU antitrust complaint [Reuters]Reuters
- Investors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five years [Yahoo! Finance]Yahoo! Finance
EW
Earnings
- 4/25/24 - Beat
EW
Sec Filings
- 5/13/24 - Form 4
- 5/13/24 - Form 4
- 5/13/24 - Form 4
- EW's page on the SEC website